Quantitative PCR-based expression analysis demonstrated significant decreases of MUPCDH levels in AD samples compared to NC (fold change of expression (FC) = 4.46; p < 0.0001) as well as in the AC samples compared to NC (FC = −8.71; p < 0.0001). This evidence concerns the gene CDHR5 and Alzheimer disease.